Basic Research Center on Molecular and Cell Biology of Drug Abuse (BRCMCDA) was established in 1998 with the objectives to (1) to foster interdisciplinary approaches in drug addiction research; (2) to serve as an """"""""activity"""""""" center to coordinate and to promote all academic and scholarly activities on drug addiction research at University of Minnesota; (3) to serve as a national resource for molecular and cell biology of drug addiction research: and (4) to serve as training center for young scientists here at University of Minnesota. The goal of the Center is to promote molecular and cell biology approaches for drug addiction research, hence a thematic program is absent in the 8 scientific components. Instead, multidisciplinary approaches in the programs present fertile ground for training and interaction among scientists. The Center's activities include sponsored seminars and biannual symposium focus on the state-of-the-art techniques and breakthroughs in the field of drug addiction research. The Center has continued to raise the visibility of drug addiction research at University of Minnesota and has served as national resources in supplying investigators nationally and internationally reagents and genetically altered mice for their research programs. We wish to build on the past success and continue the missions of BRCMCBDA in promoting drug addiction research and training at University of Minnesota. Thus the proposed structure of BRCMCBDA remains to consist of 8 scientific components supported by an administrative core. The principal investigators involved in these components have demonstrated records of past collaboration and are committed to the mission of the Center. However, in order to establish a formal recruiting mechanism, a """"""""seed grants"""""""" program will be implemented to create an opportunity for investigators not associated with the Center to test their hypotheses or new techniques in drug addiction research. Such program not only will enhance the existing research programs within the Center, but also will establish the bases for future components of the Center and grants application in drug addiction research. Hence, together with the other programs of the Center, BRCMCBDA will continue to be a research training center and national resource on the understanding of the molecular mechanism of drug addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA011806-08
Application #
6903398
Study Section
Special Emphasis Panel (ZDA1-RXL-E (01))
Program Officer
Pollock, Jonathan D
Project Start
1998-09-30
Project End
2008-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
8
Fiscal Year
2005
Total Cost
$1,046,947
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2017) Phosphorylation of poly(rC) binding protein 1 (PCBP1) contributes to stabilization of mu opioid receptor (MOR) mRNA via interaction with AU-rich element RNA-binding protein 1 (AUF1) and poly A binding protein (PABP). Gene 598:113-130
Kibaly, Cherkaouia; Lin, Hong-Yiou; Loh, Horace H et al. (2017) Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo. Pharmacol Res 119:153-168
Kibaly, Cherkaouia; Kam, Angel Y F; Loh, Horace H et al. (2016) Naltrexone Facilitates Learning and Delays Extinction by Increasing AMPA Receptor Phosphorylation and Membrane Insertion. Biol Psychiatry 79:906-16
Meng, Jingjing; Roy, Sabita (2016) Study of Epithelium Barrier Functions by Real-time TER Measurement. Bio Protoc 6:
Banerjee, S; Sindberg, G; Wang, F et al. (2016) Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol 9:1418-1428
Banerjee, Santanu; Ninkovic, Jana; Meng, Jingjing et al. (2015) Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis. Sci Rep 5:11384
Wang, Yan; Wang, Yan-Xia; Liu, Ting et al. (2015) ?-Opioid receptor attenuates A? oligomers-induced neurotoxicity through mTOR signaling. CNS Neurosci Ther 21:8-14
Meng, Jingjing; Banerjee, Santanu; Li, Dan et al. (2015) Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization. Sci Rep 5:10918
Kotecki, Lydia; Hearing, Matthew; McCall, Nora M et al. (2015) GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner. J Neurosci 35:7131-42
Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2015) Analysis of epigenetic mechanisms regulating opioid receptor gene transcription. Methods Mol Biol 1230:39-51

Showing the most recent 10 out of 308 publications